REN001PPAR delta agonistsMuscular atrophyRandomized controlled trialPhase 1 clinical trialHealthy volunteersImmobilizationObjective: Assess the safety, tolerability and effects of the Peroxisome Proliferator-Activated Receptor 未 (PPAR未) agonist REN001 on muscle recovery after limb immobilization. Methods: ...